Anti-FTHL17 monoclonal antibody

Pre-made anti-FTHL17 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FTHL17/FTHL17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0866-Ab-1/ GM-Tg-hg-IP0866-Ab-2Anti-Human FTHL17 monoclonal antibodyHuman
GM-Tg-rg-IP0866-Ab-1/ GM-Tg-rg-IP0866-Ab-2Anti-Rat FTHL17 monoclonal antibodyRat
GM-Tg-mg-IP0866-Ab-1/ GM-Tg-mg-IP0866-Ab-2Anti-Mouse FTHL17 monoclonal antibodyMouse
GM-Tg-cynog-IP0866-Ab-1/ GM-Tg-cynog-IP0866-Ab-2Anti-Cynomolgus/ Rhesus macaque FTHL17 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0866-Ab-1/ GM-Tg-felg-IP0866-Ab-2Anti-Feline FTHL17 monoclonal antibodyFeline
GM-Tg-cang-IP0866-Ab-1/ GM-Tg-cang-IP0866-Ab-2Anti-Canine FTHL17 monoclonal antibodyCanine
GM-Tg-bovg-IP0866-Ab-1/ GM-Tg-bovg-IP0866-Ab-2Anti-Bovine FTHL17 monoclonal antibodyBovine
GM-Tg-equg-IP0866-Ab-1/ GM-Tg-equg-IP0866-Ab-2Anti-Equine FTHL17 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0866-Ab-1/ GM-Tg-hg-IP0866-Ab-2; GM-Tg-rg-IP0866-Ab-1/ GM-Tg-rg-IP0866-Ab-2;
GM-Tg-mg-IP0866-Ab-1/ GM-Tg-mg-IP0866-Ab-2; GM-Tg-cynog-IP0866-Ab-1/ GM-Tg-cynog-IP0866-Ab-2;
GM-Tg-felg-IP0866-Ab-1/ GM-Tg-felg-IP0866-Ab-2; GM-Tg-cang-IP0866-Ab-1/ GM-Tg-cang-IP0866-Ab-2;
GM-Tg-bovg-IP0866-Ab-1/ GM-Tg-bovg-IP0866-Ab-2; GM-Tg-equg-IP0866-Ab-1/ GM-Tg-equg-IP0866-Ab-2
Products NameAnti-FTHL17 monoclonal antibody
Formatmab
Target NameFTHL17
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FTHL17 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0866-Ag-1Recombinant multi-species FHL17/ FTHL17/ CT38 protein


    Target information

    Target IDGM-IP0866
    Target NameFTHL17
    Gene ID53940,71996,707851
    Gene Symbol and Synonyms1600014K23Rik,CT38,FTHL17,Fthl17a
    Uniprot AccessionQ9BXU8
    Uniprot Entry NameFHL17_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132446
    Target ClassificationN/A

    The target: FTHL17, gene name: FTHL17, also named as CT38. This gene encodes a ferritin heavy chain-like protein. This gene is primarily expressed in embryonic germ cells. The encoded protein may lack ferroxidase activity. Multiple pseudogenes of this gene are found on chromosome X. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.